Drug industry presses FDA to allow more online ads Nov 14, 2009
In April, the FDA fired off warning letters to Pfizer Inc., GlaxoSmithKline PLC and a dozen other drugmakers for search engine ads that did not mention drug risks. The ads called sponsored links appear on the screen margins of sites like Google when users search for certain key words. (Yahoo News -- Pharmaceutical Industry News)
Stiefel plant in Greene County faces closure, with loss of 260 jobs Nov 13, 2009
The Stiefel plant in Greene County is facing closure by new parent company GlaxoSmithKline within a few years, resulting in the loss of 260 jobs ... GlaxoSmithKline closed this summer on a $3. (Albany Times Union)
Drug industry disputes profit claims Nov 13, 2009
PhRMA s members include Schering-Plough Corp., Pfizer Inc., Merck & Co. Inc. and GlaxoSmithKline. contending the drug industry could gain as much as $137 billion over the next four years if health reforms pass. (Phoenix Business Journal, AZ)
Health: Firms differ on ARV contracts Nov 13, 2009
GlaxoSmithKline said it had some challenges that the government was addressing. Adcock Ingram, Cipla Medpro and Sonke Pharmaceuticals were happy with the way the government was managing the contract. (Business Report, South Africa)
Stiefel closing Greene County operation, 260 jobs cut Nov 13, 2009
GlaxoSmithKline will close the facility by the end of 2012 ... Mathes said the group is prepared to offer tax credits, low-interest loans, state grants, low-cost bonds and other incentives to convince GlaxoSmithKline to keep the plant open ... In a brief statement, GlaxoSmithKline said the decision to close the plant results from under-utilized capacity across all of Stiefel and GlaxoSmithKline, or GSK.. (Albany Business Review, NY)
Stiefel closing, taking 250 jobs with it Nov 12, 2009
Stiefel Labs in Oak Hill will be closed by 2012, owner GlaxoSmithKline announced Wednesday ... Owner GlaxoSmithKline issues terse statement; other plants to shutter ... Published: Thursday, November 12, 2009 2:16 AM EST DURHAM Stiefel Labs, the Oak Hill-based skin-care product maker and one of Greene County s largest industries, will close by 2012, its owner, GlaxoSmithKline, announced in a terse statement Wednesday. (Catskill Daily Mail, NY)
Jubilant runs out of steam on St Nov 12, 2009
That itself was high, considering the fact that some frontline pharma stocks like Cipla, Sun Pharma, GlaxoSmithKline Pharma and Lupin are trading in the 21-24 range. After a single-day jump of Rs 45 jump, the stock is now trading at a consolidated P/E multiple of 37. (India Times)
More shots available, but still hard to find Nov 12, 2009
The United States also has contracts with four other vaccine makers for influenza immunizations AstraZeneca unit MedImmune, Novartis,, CSL and GlaxoSmithKline, whose H1N1 vaccine has yet to be licensed by the U.S. Food and Drug Administration. A U.S. senator proposed legislation to require employers to give workers seven paid days off to cope with flu. (MSNBC -- Health)
Swine Flu Deaths in Europe Doubling Weekly, Heading to Peak, Agency Says Nov 11, 2009
The Norwegian government temporarily removed the requirement for a prescription for Roche Holding AGs and GlaxoSmithKline Plcs last week, enabling pharmacies to directly dispense the antiviral drugs. It also started an intensive-care registry to track severely ill swine flu patients last month. (Bloomberg -- Germany)
WHO Expects Donated Vaccine Shipments Through May Nov 11, 2009
GENEVA (November 10, 2009)--The World Health Organization says it expects GlaxoSmithKline to complete shipping donations of swine flu vaccine to poor countries by May 2010. WHO spokesman Gregory Hartl said Tuesday the global body hopes countries will start receiving the first of 50 million doses from Glaxo late this month or early next month. (KWTX.com, TX)
GlaxoSmithKline to Donate 50 Million Doses of H1N1 Nov 11, 2009
LONDON -(Dow Jones)- GlaxoSmithKline PLC (GSK), the research-based pharmaceutical company said Tuesday it has signed an agreement with the World Health Organisation, or WHO, to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine for ddistributionin developing countries. MAIN FACTS. (SmartMoney)
Pa. women earn less, gender gap narrows Nov 10, 2009
Besides enrolling their female executives in the program, businesses including Westinghouse Electric Co., GlaxoSmithKline, Giant Eagle, EQT, Highmark and the University of Pittsburgh Medical Center allow program participants to use their board rooms for meetings and activities. "When you look at the 20 percent deficit in earnings, it's still a significant gap compared with the number of women entering the work force," said Ms. Arrington. (Pittsburgh Post-Gazette, PA)
GSK to donate 50 mln doses of H1N1 vaccine to WHO Nov 10, 2009
Tue, 08:47 10 Nov 2009 GMT. Drugmaker sees first shipments to WHO by end of November. (AlertNet)
CDC Says U.S. Making Progress on Swine Flu Vaccine Nov 10, 2009
The United States buys both seasonal and H1N1 vaccine from five makers -- GlaxoSmithKline Plc, AstraZeneca Plc's MedImmune unit, Novartis, Sanofi-Aventis, and CSL Limited. Robert Blendon of the Harvard School of Public Health and colleagues found that only 5 percent of Americans they polled have been vaccinated against H1N1 so far. (MEDLINEplus)
Genmab Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL Nov 9, 2009
Ofatumumab is being developed under a co-development and commercialization agreement between Genmab and GlaxoSmithKline ... Genmab(R); the Y-shaped Genmab logo(R); HuMax(R); HuMax-CD20(R); HuMax-EGFr(TM); HuMax-IL8(TM); HuMax-TAC(TM); HuMax-HepC(TM); HuMax-CD38(TM); HuMax-CD32b(TM); HuMax-TF(TM); HuMax-Her2(TM); HuMax-VEGF(TM) and UniBody(R) are all trademarks of Genmab A/S. Arzerra(TM) is a trademark of GlaxoSmithKline. (Primezone Releases)
Animals need to be closely watched for flu Nov 7, 2009
GlaxoSmithKline and Sanofi-Aventis are among some 25 companies producing pandemic vaccine and other drugmakers including Switzerland's Roche Holding are making antiviral therapies for use as a frontline H1N1 drug. Click for related content. (MSNBC -- Health)
Experts Say H1N1 Outrunning Vaccine Nov 6, 2009
GlaxoSmithKline stands to gain 3 BILLION from H1N1 vaccine sales. Novartis stands to gain 1. (CBS News)
Will Promising New Malaria Vaccine Deliver? Nov 6, 2009
The Path Malaria Initiative, funded by the Bill and Melinda Gates Foundation and the pharmaceutical company GlaxoSmithKline, says it is taking unprecedented measures to try and ensure that countries will be ready to distribute the malaria vaccine, called RTSS, as soon as it's approved ... While African scientists and doctors run the final trial using 16,000 babies and toddlers in seven different Sub-Saharan African countries, both GlaxoSmithKline and Path-MVI are working with African government... (ABC News)
W-S Industries for Blind honored Nov 6, 2009
The others are Blue Cross Blue Shield of North Carolina and GlaxoSmithKline. Winston-Salem Industries for the Blind is the largest employer of the visually impaired in the state, the announcement said, and 42 percent of all its workers are age 50 or older. (Triad Business Journal, NC)
Stiefel to close Coral Gables facility Nov 5, 2009
"The move will help Stiefel achieve its goal to 'Work as One' and is aligned with the GlaxoSmithKline Global Real Estate Program, which aims to optimize the use of facilities and simplify the company's operating model.". Sales of Stiefel s products for 2008 were about $900 million and sales of GSK s prescription dermatology products were about $550 million, according to a news release. (South Florida Business Journal, FL)
Africa: Continent to Benefit From World's Largest Malaria Vaccine Trial Nov 5, 2009
GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during early development to warrant Phase III testing. It is the leading vaccine candidate in the global effort by the PATH Malaria Vaccine Initiative (MVI) to develop a malaria vaccine. (allAfrica.com)
Africa: Malaria Vaccine Draws Closer Nov 5, 2009
GlaxoSmithKline Biologicals' RTS,S is the first malaria vaccine to demonstrate a high level of efficacy. The vaccine is presently negotiating what will be the final hurdle before release as it enters Phase III trials in seven African countries. (allAfrica.com)
The Swine Flu Vaccine Screw-Up Nov 5, 2009
But let's stop a minute and also ask: Who really screwed up here -- the government or private pharmaceutical com 00004000 panies, including GlaxoSmithKline, Novartis, and three others that had agreed to manufacture and deliver the vaccine by late fall ... onevote--"GlaxoSmithKline, Novartis and three others that had agreed to manufacture vaccine gleefully gobbled up 2 billion dollars worth of government contracts...."This is from the article above. (CBS News -- Opinion)
Nicotine Patch Plus Lozenge Best for Quitting Smoking Nov 4, 2009
Medication was provided free by drug maker GlaxoSmithKline. Several of the study authors reported financial ties to different pharmaceutical companies. (MEDLINEplus)
Human Genome reports positive data on lupus drug Nov 4, 2009
NEW YORK: Human Genome Sciences and GlaxoSmithKline said Monday their experimental lupus treatment passed another key goal on its path to potentially becoming the first new drug for the disease in decades ... Human Genome of Rockville, Maryland, and GlaxoSmithKline, based in the UK, plan to seek Food and Drug Administration regulatory approval in the first half of 2010. (India Times, India)
Swine Flu Vaccine in Canada Nov 4, 2009
In Canada, the vaccine being offered to people is called Areparnix by its maker GlaxoSmithKline Inc. It s also known as AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine. A needle is used for this injection and it is usually done in the arm. (Suite101.com)
Gaza put on alert over swine flu Nov 4, 2009
Doctors in Gaza and the West Bank say they were expecting an initial 20,000 doses from pharmaceutical giant GlaxoSmithKline, but are still waiting with the order running late. They were hoping to vaccinate 4,000 pilgrims leaving Gaza for Mecca and the Hajj later this month. (CNN -- International)
World largest malaria vaccine trial underway in Africa Nov 4, 2009
GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during early development to warrant Phase III testing ... "GSK's approach is to make every effort possible to accelerate the availability of this life-saving vaccine," said Mr. Jean Stphenne, President and General Manager, GlaxoSmithKline Biologicals. (Xinhuanet, China)
Pfizer, GSK launch HIV drug company Nov 4, 2009
A new company, ViiV Healthcare, will assume control of current HIV treatments from Pfizer (NYSE: PFE) and GlaxoSmithKline (NYSE: GSK) and also develop new treatments ... GlaxoSmithKline and Pfizer, which will have ownership stakes in ViiV Healthcare of 85 percent and 15 percent, respectively, announced the collaborative effort in April. (St. Louis Business Journal, MO)
J&J to slash 7,000 to 8,000 jobs Nov 4, 2009
Jlash 7,000 to 8,000 jobs - Yahoo. Search Type Choose a search type from the items below. (Yahoo News -- Pharmaceutical Industry News)
New vaccine offers hope in malaria battle Nov 4, 2009
More than $500 million has been spent on the combined efforts by drug maker GlaxoSmithKline and the PATH Malaria Vaccine Initiative, which is funded by the Bill da Gates Foundation. Originally published in the Athens Banner-Herald on Wednesday, November 04, 2009. (Athens Banner-Herald)
Joe Lieberman, I-Conn. Nov 4, 2009
Lieberman introduced legislation vastly extending patent protection for pharmaceutical companies -- notably including GlaxoSmithKline, a top client of his wife's firm. The best that can be said about the Lieberman family's conflict of interest is that it appears to have ended in 2005 -- while the Bayh family continues to collect enormous amounts of money from the same health insurance and drug companies that will benefit from her husband s actions. (Salon)
First malaria vaccine 'ready in 3-5 years' Nov 4, 2009
"We believe and hope that in three to five years from today we will be able to put the vaccine in use," Joe Cohen, the vaccine's co-inventor and a GlaxoSmithKline researcher told AFP.. Up to 16,000 children aged between six weeks to 17 months in seven African countries -- Burkina Faso Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania -- will be vaccinated. (Yahoo! Asia News)
World's largest malaria vaccine trial now underway in 7 African countries Nov 3, 2009
GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during early development to warrant Phase III testing ... "GSK's approach is to make every effort possible to accelerate the availability of this life-saving vaccine," said Mr. Jean Stphenne, President and General Manager, GlaxoSmithKline Biologicals ... About GlaxoSmithKline Biologicals (GSK Bio). (EurekAlert!)
U.S. to Receive 10M More Doses of H1N1 Vaccine Nov 3, 2009
Sebelius said those initial estimates were based on "overly optimistic" predictions by the five contracted vaccine makers for the U.S. market MedImmune, a unit of AstraZeneca, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline and Novartis. But production was now increasing and vaccine doses were being shipped seven days a week, Sebelius told CNN.. (Fox News)
GlaxoSmithKline Launches Specialist HIV Company Nov 3, 2009
LONDON -(Dow Jones)- Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer (PFE) said Tuesday they have launched ViiV Healthcare, a new specialist company dedicated to delivering advances in HIV treatment and care. MAIN FACTS. (SmartMoney)
Google best work place Nov 3, 2009
GlaxoSmithKline and Alcatel-Lucent appear in the engineering ranking, yet not in the business ranking. Meanwhile, in the list of top 50 employers for engineering students Microsoft is followed by IBM at the third spot, BMW (fourth), Intel (fifth), General Electric (sixth), Sony (seventh), Siemens (eighth), Shell (ninth) and Procter e (10th). (India Times)
New vaccine offers hope in Africa's malaria battle Nov 3, 2009
More than $500 million has been spent on the combined efforts by drug maker GlaxoSmithKline and the PATH Malaria Vaccine Initiative, which is funded by the BillaGates Foundation ... Joe Cohen, a top researcher for GlaxoSmithKline, said all the data collected during testing have been encouraging ... GlaxoSmithKline "is committed to making sure pricing will never be a barrier to access for this vaccine," Cohen said. (Atlanta Journal-Constitution -- Health)
UN says $39 bln would stem child pneumonia deaths Nov 2, 2009
Mon, 2 Nov 08:36:31 GMT. 9 per child could save 5. (AlertNet)
Human Genome, Glaxo lupus drug works in 2nd trial Nov 2, 2009
Mon, 2 Nov 09:10:21 GMT. 2 pct of patients respond vs 33. (AlertNet)
How I got well in India for $50 Nov 1, 2009
" Less than a year later, having pocketed $77,000 in salary, she quit without explanation -- just as her husband was facing a tough primary that he would eventually lose. Throughout the campaign, Hadassah Lieberman, her husband and their spokespersons explicitly refused to discuss her professional activities, except to note that she had not been required to register as a lobbyist. But her stint at Hill & Knowlton was merely one episode in a professional lifetime devoted to the corporate health... (Salon)
Three schools close due to illness Nov 1, 2009
GlaxoSmithKline Arepanrix AdjuvantedH1N1 Influenza Vaccine Ingredients/Toxicity ... GlaxoSmithKline Pandemrix AdjuvantedH1N1 Influenza Vaccine Ingredients/Toxicity ... GlaxoSmithKline Fluarix 2009-2010Formula Ingredients/Toxicity. (Park Hills Daily Journal, MO)
H1N1 vaccine supply is impacted by various factors Nov 1, 2009
Arlene Porcell-Pharr of CDC Media Relations confirmed Thursday that vaccine manufacturer GlaxoSmithKline has yet to receive FDA approval. This leaves four manufacturers of the vaccine to serve the U.S. Sanofi Pasteur, Novartis, MedImmune and CSL.. (Williston Daily Herald, ND)
Gates Foundation picks new PR chief Oct 31, 2009
Prior to Standard, James managed external relations for GlaxoSmithKline (NYSE: GSK). Most Read Stories. (Puget Sound Business Journal, WA)
GlaxoSmithKline Posts 11% Rise in Q3 Net Profit Oct 31, 2009
B), GlaxoSmithKline PLC (GSK), (GSK.LN), (GB000925), (INE159A0), (US37733W)) at SmartMoney ... BANGALORE -(Dow Jones)- GlaxoSmithKline Pharmaceuticals Ltd. (500660 ... BY), the Indian unit of GlaxoSmithKline PLC (GSK.LN), Friday said its third quarter net profit rose 6. (SmartMoney)
Hank Skorny Appointed Senior Vice President At RealNetworks Oct 30, 2009
Mr. Skorny studied at Drexel University where he was awarded a scholarship for his early novel research in Xenon Fluorides, and by GlaxoSmithKline for his research in computer modeling of complex biochemicals. ABOUT REALNETWORKS. (Yahoo! Wire -- Entertainment News)
Are Swine Flu Fears Overblown? Oct 30, 2009
Similar news had already come from China, and GlaxoSmithKline () followed shortly afterward, finding the same held true for its vaccine, which Germany is putting into effect as of this week. Unexpectedly, the company found a second shot for adults was unnecessary. (BusinessWeek)
Relenza sales hit $331m for first quarter Oct 29, 2009
Biotechnology company Biota said it had received written notification from its global marketing partner GlaxoSmithKline (GSK) that its anti-influenza drug Relenza had recorded sales of $331 million for the first quarter generating indicative royalties of $24. 1 million. (Sydney Morning Herald -- Business)
UK: GSK posts 11% surge in profit Oct 29, 2009
GlaxoSmithKline (GSK) lifted third-quarter net profit by 11 percent on the back of strong sales in emerging markets and at its consumer health division, the drug maker said yesterday. Net profit rose to 1. (Business Report, South Africa)
Options lead to $86.5M charge Oct 29, 2009
The firm has handled or is working on deals for GlaxoSmithKline, BHP Billiton, Kraft Foods, Barclay's, Cisco, Anheuser-Busch InBev, Nortel, Amazon. com and Pfizer, among others. (San Francisco Chronicle -- Business)
Healthy rise in GSK profits Oct 29, 2009
Europe's biggest drugs company, GlaxoSmithkline, has announced a rise in profits and sales for the third quarter. The company says it has benefitted from moving away from "white pills and western markets" - but it will also see anti-virals and swine flu vaccine further boosting its earnings by the end of the year. (BBC News -- Business)
Vaccine experts prepare swine flu guidance for WHO Oct 29, 2009
Thu, 03:31 29 Oct 2009 GMT. Vaccine experts present advice to U.N. health agency * WHO to circulate guidance next week. (AlertNet)
Joe Conason noted: Oct 29, 2009
Among Hill ton's clients when Mrs. Lieberman signed on with the firm last year was GlaxoSmithKline, the huge British-based drug company that makes vaccines along with many other drugs ... Lieberman introduced a bill in April 2005 (the month after his wife joined Hill ton) that would award billions of dollars in new "incentives" to companies like GlaxoSmithKline to persuade them to make more new vaccines. (Harper's Magazine)
Experts offer policy recommendations for improving medication adherence Oct 28, 2009
The group, which includes the American College of Cardiology, GlaxoSmithKline, the National Association of Chain Drug Stores, the National Consumers League and the Pharmaceutical Research and Manufacturers of America, focused their recommendations on the areas of quality improvement, care coordination, health information technology, patient/provider education and engagement, and health services research ... GlaxoSmithKline one of the world's leading research-based pharmaceutical and healthcare... (EurekAlert!)
H1N1 vaccine makers struggle with U.S. shot Oct 28, 2009
WASHINGTON - GlaxoSmithKline has yet to get U.S. government approval for its swine flu vaccine, the company said on Tuesday, while Novartis said it was still struggling to make vaccines. A U.S. senator accused the Health and Human Services department of over-promising how many and how quickly H1N1 vaccines could be delivered, as disgruntled people lined up outside clinics across the United States seeking immunization. (MSNBC -- Health)
Destiny Bus visits Bartlett Yancey Oct. 8 Oct 28, 2009
Its principal funders are the State of North Carolina and GlaxoSmithKline, with additional support from Bio-Rad Laboratories and from the North Carolina Biotechnology Center. Name. (Yanceyville Caswell Messenger, NC)
H1N1 vaccine only registered for use on those 18 and above Oct 28, 2009
" onclick="Next();" src="/images/butt_next. Just because you give an adult-vaccine to a child, accepting the side effects, you may not get the benefit you want because it could very well be that the child needs more, or less, and may not get enough protection. (Channelnewsasia.com)
FDA gives GlaxoSmithKline green light for leukemia drug Arzerra Oct 28, 2009
CLL affects between 2,000 and 3,000 people in the U.S., but only about 1,000 of them could benefit from Arzerra, GlaxoSmithKline said. The drug was created through a partnership between GSK (NYSE: GSK) and (OMX: GEN). (Raleigh Triangle Business Journal, NC)
Securities Litigation Against NutriSystem Is Thrown Out Oct 28, 2009
The suit alleged that NutriSystem was aware that its sales were threatened by the competition from Alli, an over-the-counter anti-obesity drug produced by GlaxoSmithKline, but that the company continued to tout its future earnings prospects. But Nutrisystem's lawyers -- Marc J. Sonnenfeld and Karen Pieslak Pohlmann of Morgan Lewis & Bockius -- argued that the case should be dismissed because the plaintiffs had failed to establish "scienter," meaning there was insufficient evidence that any... (Law.com)
In Germany, A Better H1N1 Vaccine For Politicians? Oct 27, 2009
The vaccine, manufactured by GlaxoSmithKline, contains an immune-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. Then, after a report was leaked to the German media last week, the Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. (Time.com)
Experimental Drug OK'd Oct 27, 2009
The FDA said Peramivir should only be used in patients who have not responded to or can't take the oral antiviral drug Tamiflu, made by Roche or Relenza, which is an inhaled drug made by GlaxoSmithKline PLC. Like Tamiflu and Relenza, Peramivir works by inhibiting neuraminidase, an enzyme that's involved with the spread of the influenza virus within the body. The federal Centers for Disease Control and Prevention asked the FDA to grant Peramivir emergency use to help cope with the influenza... (Fox News)
GSK and Genmab Receive Accelerated Approval for Arzerra Oct 27, 2009
Today, GlaxoSmithKline (GSK) and Genmab A/S (Copenhagen: - ) announced the accelerated approval of Arzerra(TM) (ofatumumab) from the U.S. Food and Drug Administration for use in patients with chronic lymphocytic leukemia (CLL) that is refractory to fludarabine and alemtuzumab ... D., Vice President and Medicines Development Leader at GlaxoSmithKline ... GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of... (Primezone Releases)
Genmab Achieves Milestone in Arzerra Collaboration Oct 27, 2009
(ofatumumab) under the terms of its collaboration with GlaxoSmithKline (GSK) ... Genmab(R); the Y-shaped Genmab logo(R); HuMax(R); HuMax-CD20(R); HuMax-EGFr(TM); HuMax-IL8(TM); HuMax-TAC(TM); HuMax-HepC(TM); HuMax-CD38(TM); HuMax-CD32b(TM); HuMax-TF(TM); HuMax-Her2(TM); HuMax-VEGF(TM) and UniBod (R) are all trademarks of Genmab A/S. Arzerra(TM) is a trademark of GlaxoSmithKline. (Primezone Releases)
Who Should Get the Swine Flu Vaccin... Oct 27, 2009
GlaxoSmithKline is making the H1N1 influenza vaccine for Canada, and the federal government has a deal with this company to produce more of the vaccine if it s needed. Although everyone who wants a shot can get one, there will be limited supplies of the vaccine in the beginning. (Suite101.com)
Ala. court rejects $274M verdicts in drug cases Oct 27, 2009
The court overturned jury verdicts against the drug companies AstraZeneca, Novartis and GlaxoSmithKline, accused by the state of fraudulently manipulating prices of drugs for Medicaid recipients ... "This confirms our position that GSK reported clear and accurate prices, that GSK's pricing practices were consistent with established industry standards and that the state understood full well the pricing benchmarks that GSK reported," said GlaxoSmithKline spokeswoman Mary Anne Rhyne ... Later in... (Yahoo News -- Pharmaceutical Industry News)
